Why It (Also) Matters What Infectious Disease Epidemiologists Call “Disease”

Authors

  • David Stoellger Fakultät für Geschichtswissenschaft, Philosophie und Theologie, Universität Bielefeld, Bielefeld, Germany https://orcid.org/0000-0001-9842-2196

DOI:

https://doi.org/10.5195/pom.2023.149

Keywords:

Disease, Definition of disease, Philosophy of epidemiology

Abstract

Infectious diseases figure prominently as (counter)examples in debates on how to conceptualize “disease.” But crucial epidemiological distinctions are often not heeded in the debate, and pathological and clinical perspectives focusing on individual patients are favored at the expense of perspectives from epidemiology focusing on populations. In clarifying epidemiological concepts, this paper highlights the distinct contributions infectious disease epidemiology can make to the conception of “disease,” and the fact that this is at least tacitly recognized by medical personnel and philosophers. Crucially, infectious disease epidemiology can help elucidate how carrying and transmitting infectious, communicable entities is a disease, even if the carriers themselves are not directly affected by symptoms detrimental to them.

 

References

Abubakar, Ibrahim. 2016. “Introduction to Infectious Disease Epidemiology.” In Infectious Disease Epidemiology, edited by Ibrahim Abubakar, Helen R. Stagg, Ted Cohen and Laura C. Rodrigues, 26–35. Oxford: Oxford University Press. https://doi.org/10.1093/med/9780198719830.001.0001.

Boorse, Christopher. 1975. “On the Distinction between Disease and Illness.” Philosophy & Public Affairs 5, no. 1: 49–68. https://www.jstor.org/stable/2265020.

———. 1977. “Health as a Theoretical Concept.” Philosophy of Science 44, no. 4: 542–573. https://doi.org/10.1086/288768.

———. 1997. “A Rebuttal on Health.” In Biomedical Ethics Reviews, edited by James M. Humber and Robert F. Almeder, 1–135. New York: Springer.

———. 2014. “A Second Rebuttal on Health.” Journal of Medicine and Philosophy 39, no. 6: 683–724. https://doi.org/10.1093/jmp/jhu035.

———. 2023. “Boundaries of Disease: Disease and Risk.” Medical Research Archives 11, no. 4: 1–24. https://doi.org/10.18103/mra.v11i4.3599.

Broadbent, Alex. 2013. Philosophy of Epidemiology. Basingstoke: Palgrave MacMillan.

———. 2019. “Health as a Secondary Property.” British Journal of Philosophy of Science 70: 609–627. https://doi.org/10.1093/bjps/axx014.

Carton, James. 2012. Oxford Handbook of Clinical Pathology. Oxford: Oxford University Press.

Cooper, Rachel. 2002. “Disease.” Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 33, no. 2: 263–282. http://dx.doi.org/10.1016/S0039-3681(02)00018-3.

De Cock, Kevin M., Siobhan P. Crowley, Ying-Ru Lo, Reuben M. Granich, and Brian G. Williams. 2009. “Preventing HIV Transmission with Antiretrovirals.” Bulletin of the World Health Organization 87, no. 7: 488. https://doi.org/10.2471%2FBLT.09.067330.

DeVito, Scott. 2000. “On the Value-Neutrality of the Concepts of Health and Disease: Unto the Breach Again.” Journal of Medicine and Philosophy 25, no. 5: 539–567. https://doi.org/10.1076/0360-5310(200010)25:5;1-W;FT539.

Finkelstein, Paige, Laura Teisch, Casey J. Allen, and Gabriel Ruiz. 2016. ‘Tetanus: A Potential Public Health Threat in Times of Disaster.” Prehospital and Disaster Medicine 32, no. 3: 339–342. https://doi.org/10.1017/s1049023x17000012.

Finlay, B.B. and Fellows of CIFAR (Canadian Institute for Advanced Research). 2020. “Are Noncommunicable Diseases Communicable?” Science 367, no. 6475: 250–251. https://doi.org/10.1126/science.aaz3834.

Fishman, Jay A. 2010. “The Biopsy in the Diagnosis of Infection: Clinical Approach.” In Diagnostic Pathology of Infectious Disease, edited by Richard L. Kradin, 17–22. Philadelphia: Saunders Elsevier.

Gieseke, Johan. 2017. Modern Infectious Disease Epidemiology. 3rd edition. Boca Raton: CRC Press.

Giroux, Élodie. 2009. “Définir objectivement la santé: Une évaluation du concept bio statistique de Boorse à partir de l'épidémiologie moderne.” Revue philosophique de la France et de l’étranger 1, no. 134: 35–58. https://doi.org/10.3917/rphi.091.0035.

Hesslow, Germund. 1993. “Do We Need a Concept of Disease?” Theoretical Medicine 13: 1–14. https://doi.org/10.1007/BF00993984.

Kaper, James B., James P. Nataro, and Harry L.T. Mobley. 2004. “Pathogenic Escherichia Coli.” Nature Reviews: Microbiology 2, no. 2: 123–140. https://doi.org/10.1038/nrmicro818.

Khanfar, Nidal. 2004. “Hydatid Disease: A Review and Update.” Current Anaesthesia and Critical Care 15, no. 3: 173–183. http://dx.doi.org/10.1016/j.cacc.2004.06.002.

Kingma, Elselijn. 2010. “Paracetamol, Poison, and Polio: Why Boorse’s Account of Function Fails to Distinguish Health and Disease.” British Journal for the Philosophy of Science 61, no. 2: 241–264. http://dx.doi.org/10.1093/bjps/axp034.

Klenk, Michael and Hein Duijf. 2021. “Ethics of Digital Contact Tracing and COVID-19: Who Is (Not) Free to Go?” Ethics and Information Technology 23 (Supplement 1): 69–77. https://doi.org/10.1007/s10676-020-09544-0.

Knipe, David M. and Peter M. Howley. 2013. Fields Virology. Philadelphia: Lippincott Williams & Wilkins.

Krämer, Alexander, Manas Akmatov, and Mirjam Kretzschmar. 2010. “Principles of Infectious Disease Epidemiology.” In Modern Infectious Disease Epidemiology, edited by Alexander Krämer, Mirjam Kretzschmar, and Klaus Krickeberg, 85–100. New York: Springer.

Kradin, Richard L. and A. John Iafrate. 2010. “General Principles in the Diagnosis of Infection.” In Diagnostic Pathology of Infectious Disease, edited by Richard L. Kradin, 3–15. Philadelphia: Saunders Elsevier.

Kretzschmar, Mirjam and Jacco Wallinga. 2010. “Mathematical Models in Infectious Disease Epidemiology.” In Modern Infectious Disease Epidemiology, edited by Alexander Krämer, Mirjam Kretzschmar, and Klaus Krickeberg, 209–222. New York: Springer.

Kukla, Quill R. 2022. “What Counts as a Disease, and Why Does It Matter?” Journal of Philosophy of Disability 2: 130–156. https://doi.org/10.5840/jpd20226613.

Lakhani, Sunil R., Susan A. Dilly, Caroline J. Finlayson, and Mitesh Gandhi. 2016. Basic Pathology: An Introduction to the Mechanisms of Disease. Boca Raton: CRC Press.

Martín, Javier. 2006. “Vaccine-Derived Poliovirus from Long-Term Excretors and the End Game of Polio Eradication.” Biologicals 34, no. 2: 117–122. https://doi.org/10.1016/j.biologicals.2006.02.005.

McConnell, Thomas H. 2007. The Nature of Disease: Pathology for the Health Professions. Baltimore: Lippincott Williams & Wilkins.

Mitchell, Timothy J. 2003. “The Pathogenesis of Streptococcal Infections: From Tooth Decay to Meningitis.” Nature Reviews Microbiology 1, no. 3: 219–230. https://doi.org/10.1038/nrmicro771.

Murphy, Kenneth. 2012. Janeway’s Immunobiology. London: Garland Science.

Nordenfelt, Lennart. 1995 (1987). On the Nature of Health: An Action-Theoretic Approach. Dordrecht: Springer.

Oleckno, William A. 2008. Epidemiology: Concepts and Methods. Long Grove: Waveland Press.

Pradeu, Thomas, Gladys Kostyrka, and John Dupré. 2016. “Understanding Viruses: Philosophical Investigations.” Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 59: 57–63. https://doi.org/10.1016/j.shpsc.2016.02.008.

Qiu, Xueting, Ali Ihsan Nergiz, Alberto Enrico Maraolo, Isaac I. Bogoch, Nicola Low, and Muge Cevik. 2021. “The Role of Asymptomatic and Pre-symptomatic Infections in SARS-CoV-2 Transmission: A Living Systematic Review.” Clinical Microbiology 27, no. 4: 511–519. https://doi.org/10.1016/j.cmi.2021.01.011.

Rolhion, Nathalie and Arlette Darfeuille-Michaud. 2007. “Adherent-Invasive Escherichia coli in Inflamatory Bowel Disease.” Inflammatory Bowel Disease 13, no. 10: 1277–1283. https://doi.org/10.1002/ibd.20176.

Rothe, Camilla, Mirjam Schunk, Peter Sothman, Gisela Bretzel, Guenter Froeschl, Claudia Wallrauch, Thorbjörn Zimmer, et al. 2020. “Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.” New England Journal of Medicine 382, no. 10: 970-971. https://doi.org/10.1056/nejmc2001468.

Schwartz, Peter H. 2007a. “Decision and Discovery in Defining ‘Disease’.” In Establishing Medical Reality: Essays in the Metaphysics and Epistemology of Biomedical Science, edited by Harold Kincaid and Jennifer McKitrick, 47–63. Dordrecht: Springer.

———. 2007b. “Defining Dysfunction: Natural Selection, Design, and Drawing a Line.” Philosophy of Science 74, no. 3: 364–385. https://doi.org/10.1086/521970.

———. 2008. “Risk and Disease.” Perspectives in Biology and Medicine 51, no. 3: 320–334. http://doi.org/10.1353/pbm.0.0027.

Strömer, M., T. Vollmer, K. Kleesiek, and J. Dreier. 2008. “Spore-Forming Organisms in Platelet Concentrates: A Challange in Transfusion Bacterial Safety.” Transfusion Medicine 18, no. 6: 371–376. https://doi.org/10.1111/j.1365-3148.2008.00895.x.

Suerbaum, Sebastian and Pierre Michetti. 2002. “Helicobacter pylori Infection.” New England Journal of Medicine 347, no. 15: 1175–1186. https://doi.org/10.1056/nejmra020542.

Tang, Julian W., Linsey C. Marr, Yuguo Li, and Stephanie J. Dancer. 2021. “Covid-19 Has Redefined Airborne Transmission.” British Medical Journal 373, 913. https://doi.org/10.1136/bmj.n913.

Tuteja, Renu. 2007. “Malaria: An Overview.” FEBS Journal 274, no. 18: 4670–4679. https://doi.org/10.1111/j.1742-4658.2007.05997.x.

Van Basshuysen, Philippe and Lucie White. 2021. “Were Lockdowns Justified? A Return to the Facts and Evidence.” Kennedy Institute of Ethics Journal 31, no. 4: 405–428. http://dx.doi.org/10.1353/ken.2021.0028.

Van der Linden, Rik and Maartje Schermer. 2022. “Health and Disease as Practical Concepts: Exploring Function in Context-Specific Definitions.” Medicine, Health Care and Philosophy 25, no. 1: 131–140. https://doi.org/10.1007%2Fs11019-021-10058-9.

Vetter, Pauline, William A. Fischer II, Manuel Schibler, Michael Jacobs, Daniel G. Bausch, and Laurent Kaiser. 2016. “Ebola Virus Shedding and Transmission: Review of Current Evidence.” Journal of Infectious Diseases 214 (Supplement 3): 177–184. https://doi.org/10.1093/infdis/jiw254.

Wakefield, Jerome C. 2014. “The Biostatistical Theory versus the Harmful Dysfunction Analysis, Part 1: Is Part-Dysfunction a Sufficient Condition for Medical Disorder?” Journal of Medicine and Philosophy 39, no. 6: 648–682. https://doi.org/10.1093/jmp/jhu038.

Wertheim, Heiman F.L., Damian C. Melles, Margreet C. Vos, Willem van Leeuwen, Alex van Belkum, Henri A. Verbrugh, and Jan L. Nouwen. 2005. “The Role of Nasal Carriage in Staphylococcus aureus Infections.” The Lancet 5, no. 12: 751–762. https://doi.org/10.1016/s1473-3099(05)70295-4.

WHO (World Health Organization). 2019. ICD-10 Version: 2019. https://icd.who.int/browse10/2019/en#/.

———. 2023. ICD-11 for Mortality and Morbidity Statistics. https://icd.who.int/browse11/l-m/en.

Wilking, Hendrik, Michael Thamm, Klaus Stark, Toni Aebischer, and Frank Seeber. 2016. “Prevalence, Incidence Estimations, and Risk Factors of Toxoplasma gondii Infection in Germany: A Representative, Cross-sectional, Serological Study.” Nature Scientific Reports 6, 22551. https://doi.org/10.1038/srep22551.

Winsberg, Eric, Jason Brennan, and Chris W. Surprenant. 2020. “How Government Leaders Violated Their Epistemic Duties during the SARS-CoV-2 Crisis.” Kennedy Institute of Ethics Journal 30, no. 3–4: 215–242. https://doi.org/10.1353/ken.2020.0013.

Downloads

Published

2023-12-13

How to Cite

Stoellger, D. (2023). Why It (Also) Matters What Infectious Disease Epidemiologists Call “Disease”. Philosophy of Medicine, 4(1). https://doi.org/10.5195/pom.2023.149

Issue

Vol. 4 No. 1 (2023)

Section

Original Research Articles (epidemiology, public health, health policy)

License

Copyright (c) 2023 David Stoellger

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site;
    with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
  4. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
  5. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
  6. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
  7. The Author represents and warrants that:
    1. the Work is the Author’s original work;
    2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
    3. the Work is not pending review or under consideration by another publisher;
    4. the Work has not previously been published;
    5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
    6. the Work contains no libel, invasion of privacy, or other unlawful matter.
  8. The Author agrees to indemnify and hold Publisher harmless from Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
  9. The Author agrees to digitally sign the Publisher’s final formatted PDF version of the Work.

Funding data